Citation | Barlind, JG; Bauer, UA; Birch, AM; Birtles, S; Buckett, LK; Butlin, RJ; Davies, RD; Eriksson, JW; Hammond, CD; Hovland, R; Johannesson, P; Johansson, MJ; Kemmitt, PD; Lindmark, BT; Morentin Gutierrez, P; Noeske, TA; Nordin, A; O'Donnell, CJ; Petersson, AU; Redzic, A; Turnbull, AV; Vinblad, J Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). J Med Chem55:10610-29 (2012) [PubMed] Article |
---|
SMILES | Cc1nc(C)c(nc1C(N)=O)-c1ccc(cc1)[C@H]1CC[C@H](CC(N)=O)CC1 |r,wU:17.18,wD:20.22,(3.49,-36.66,;4.82,-35.89,;6.16,-36.66,;7.49,-35.89,;8.83,-36.66,;7.49,-34.35,;6.16,-33.58,;4.82,-34.35,;3.49,-33.58,;2.16,-34.34,;3.49,-32.04,;8.82,-33.59,;10.16,-34.36,;11.49,-33.58,;11.49,-32.03,;10.15,-31.27,;8.82,-32.04,;12.82,-31.26,;12.81,-29.73,;14.15,-28.95,;15.49,-29.72,;16.82,-28.95,;18.15,-29.72,;19.49,-28.95,;18.15,-31.26,;15.48,-31.26,;14.16,-32.03,)| |